CliffBio
small molecule

ZAVZPRET

ZAVEGEPANT HYDROCHLORIDE

Loss of exclusivityJune 2034latest FDA-listed patent expiry
CompanyPfizer →See this company's full patent-cliff portfolio

Drug detail

Brand nameZAVZPRET
Active ingredientZAVEGEPANT HYDROCHLORIDE
StrengthEQ 10MG BASE/SPRAY
Dosage formSPRAY, METERED
RouteNASAL
ModalitySmall molecule
FDA approvalMarch 2023
Marketing statusRX

Listed patents

PatentExpiresType
8481546June 2034substance, product

Regulatory exclusivity

CodeExpires
NCEMarch 2028

More from Pfizer

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

ZAVZPRET patent cliff — loss of exclusivity June 2034 | CliffBio